RAQUEL GONCALVES: Open Payments
NPI 1053064188 · RAHWAY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$524 in 10 payments from 7 companies in 2025. Trend: 2023 $377 · 2024 $301 · 2025 $524
Food & beverage: $354Education: $170
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $170 |
| GlaxoSmithKline, LLC. | 3 | $161 |
| CVRx, Inc. | 1 | $124 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Vifor Pharma, Inc. | 1 | $17 |
| SCPHARMACEUTICALS INC. | 1 | $17 |
Products named: NUCALA, Barostim Neo System, LEQVIO, FASENRA, Zemaira, FUROSCIX.
Industry payments across NJ — which companies pay providers there.
